{"id":"https://openalex.org/W1994095895","doi":"https://doi.org/10.1001/jama.280.8.708","title":"Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder)","display_name":"Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder)","publication_year":1998,"publication_date":"1998-08-26","ids":{"openalex":"https://openalex.org/W1994095895","doi":"https://doi.org/10.1001/jama.280.8.708","mag":"1994095895","pmid":"https://pubmed.ncbi.nlm.nih.gov/9728642"},"language":"en","primary_location":{"id":"doi:10.1001/jama.280.8.708","doi":"https://doi.org/10.1001/jama.280.8.708","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.280.8.708","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074969156","display_name":"Murray B. Stein","orcid":"https://orcid.org/0000-0001-9564-2871","observed_orcids":["https://orcid.org/0000-0001-9564-2871","https://orcid.org/0009-0006-4459-1780"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Murray B. Stein","raw_affiliation_strings":["Department of Psychiatry, University of California at San Diego, La Jolla 92093-0985, USA. mstein@ucsd.edu","Department of Psychiatry, University of California at San Diego, La Jolla 92093-0985, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of California at San Diego, La Jolla 92093-0985, USA. mstein@ucsd.edu","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Department of Psychiatry, University of California at San Diego, La Jolla 92093-0985, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032136657","display_name":"Michael R. Liebowitz","orcid":"https://orcid.org/0000-0002-8990-8845","observed_orcids":["https://orcid.org/0000-0002-8990-8845"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael R. Liebowitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045897104","display_name":"R. Bruce Lydiard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Bruce Lydiard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012820268","display_name":"Cornelius D. Pitts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cornelius D. Pitts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"William Bushnell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Bushnell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028167368","display_name":"Ivan P. Gergel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan Gergel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":56.4137,"has_fulltext":false,"cited_by_count":348,"citation_normalized_percentile":{"value":0.99962728,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"280","issue":"8","first_page":"708","last_page":"708"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.8169999718666077},{"id":"https://openalex.org/keywords/generalized-social-phobia","display_name":"generalized social phobia","score":0.9589999914169312},{"id":"https://openalex.org/keywords/social-anxiety-disorder","display_name":"social anxiety disorder","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.7200000286102295},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.7139999866485596},{"id":"https://openalex.org/keywords/liebowitz-social-anxiety-scale","display_name":"Liebowitz Social Anxiety Scale","score":0.9649999737739563},{"id":"https://openalex.org/keywords/clinical-global-impression-scale","display_name":"Clinical Global Impression Scale","score":0.800000011920929},{"id":"https://openalex.org/keywords/flexible-dosing","display_name":"flexible dosing","score":0.746999979019165},{"id":"https://openalex.org/keywords/adults","display_name":"adults","score":0.4650000035762787},{"id":"https://openalex.org/keywords/short-term-treatment","display_name":"short-term treatment","score":0.5410000085830688},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.38600000739097595},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.3889999985694885},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.38499999046325684},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.574999988079071},{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibitors","display_name":"monoamine oxidase inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.367000013589859},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.33799999952316284}],"concepts":[{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.877647876739502},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.7496619820594788},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7146576046943665},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.6689231395721436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.63711017370224},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.576022207736969},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5468615293502808},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5020501613616943},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.5017554759979248},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48388656973838806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4122054874897003},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.06461814045906067},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010556","descriptor_name":"Personality Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.280.8.708","doi":"https://doi.org/10.1001/jama.280.8.708","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.280.8.708","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:9728642","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9728642","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W20805557","https://openalex.org/W79306445","https://openalex.org/W183936472","https://openalex.org/W1267198372","https://openalex.org/W1718169872","https://openalex.org/W1971954042","https://openalex.org/W1987360315","https://openalex.org/W1993530016","https://openalex.org/W2000068457","https://openalex.org/W2005454858","https://openalex.org/W2016320303","https://openalex.org/W2019072314","https://openalex.org/W2021153010","https://openalex.org/W2026113991","https://openalex.org/W2026195579","https://openalex.org/W2026973648","https://openalex.org/W2041102675","https://openalex.org/W2049778596","https://openalex.org/W2058514732","https://openalex.org/W2065589549","https://openalex.org/W2073498739","https://openalex.org/W2074884716","https://openalex.org/W2090310653","https://openalex.org/W2092865193","https://openalex.org/W2093840588","https://openalex.org/W2094886882","https://openalex.org/W2107887700","https://openalex.org/W2127310799","https://openalex.org/W2158295423","https://openalex.org/W2159011576","https://openalex.org/W2159061031","https://openalex.org/W2162455435","https://openalex.org/W2288253513","https://openalex.org/W2313023493","https://openalex.org/W2346114762","https://openalex.org/W2409928366","https://openalex.org/W2410406081","https://openalex.org/W2417659888","https://openalex.org/W2417792371","https://openalex.org/W2914757727","https://openalex.org/W4240757079","https://openalex.org/W4249539254","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2073910294","https://openalex.org/W2145597607","https://openalex.org/W2017373355","https://openalex.org/W2114652562","https://openalex.org/W2082324164","https://openalex.org/W132721928","https://openalex.org/W2327546923","https://openalex.org/W2313023493","https://openalex.org/W2080358195","https://openalex.org/W2024886900"],"abstract_inverted_index":{"CONTEXT:":[0],"The":[1,146],"generalized":[2,67,110,314],"type":[3],"of":[4,17,24,55,103,140,150,159,168,176,182,214,222,237,263,269,285,298],"social":[5,18,68,111,315],"phobia":[6,112],"(social":[7],"anxiety":[8,19],"disorder)":[9],"is":[10,307],"a":[11,57,128,136,166,267,296],"severe":[12],"and":[13,83,92,100,219,324,330],"often":[14],"disabling":[15],"form":[16],"that":[20],"affects":[21],"approximately":[22],"5%":[23],"the":[25,53,80,173,186,204,235,275,293],"general":[26],"population.":[27],"Earlier":[28],"research":[29,333],"has":[30,46],"shown":[31],"monoamine":[32],"oxidase":[33],"inhibitors":[34],"or":[35,143,195,230,345],"benzodiazepines":[36],"to":[37,124,165],"be":[38,339],"effective":[39,309],"in":[40,64,85,274,292,322,328],"treating":[41],"this":[42],"condition,":[43],"but":[44],"neither":[45],"achieved":[47],"widespread":[48],"use.":[49],"OBJECTIVE:":[50],"To":[51],"compare":[52],"efficacy":[54,122],"paroxetine,":[56],"selective":[58],"serotonin":[59],"reuptake":[60],"inhibitor,":[61],"with":[62,66,157,279,313,347],"placebo":[63,226,294],"adults":[65],"phobia.":[69,316],"DESIGN:":[70],"Twelve-week,":[71],"multicenter,":[72],"randomized,":[73],"double-blind":[74],"trial.":[75],"SETTING:":[76],"Thirteen":[77],"centers":[78],"across":[79],"United":[81],"States":[82],"1":[84,121],"Canada.":[86],"PARTICIPANTS:":[87],"Between":[88],"April":[89],"13,":[90],"1995,":[91],"February":[93],"28,":[94],"1996,":[95],"187":[96],"persons":[97,216,224],"meeting":[98],"Diagnostic":[99],"Statistical":[101],"Manual":[102],"Mental":[104],"Disorders,":[105],"Fourth":[106],"Edition":[107],"criteria":[108],"for":[109,118,311],"were":[113,227,255],"randomized":[114],"(and":[115],"183":[116],"returned":[117],"at":[119,234,272,290],"least":[120],"assessment)":[123],"treatment.":[125,177],"INTERVENTION:":[126],"After":[127],"1-week,":[129],"single-blind,":[130],"placebo,":[131],"run-in":[132],"period,":[133],"patients":[134,312],"received":[135],"double-blind,":[137],"11-week":[138],"course":[139],"either":[141],"paroxetine":[142,151,218,276],"matching-image":[144],"placebo.":[145],"initial":[147],"daily":[148],"dosage":[149],"(or":[152],"placebo)":[153],"was":[154],"20":[155],"mg":[156],"increases":[158],"10":[160],"mg/d":[161],"weekly":[162],"(flexible":[163],"dosing":[164],"maximum":[167],"50":[169],"mg/d)":[170],"permitted":[171],"after":[172],"second":[174],"week":[175],"MAIN":[178],"OUTCOME":[179],"MEASURES:":[180],"Number":[181],"responders":[183],"based":[184],"on":[185,203],"Clinical":[187],"Global":[188,190],"Impression":[189],"Improvement":[191],"Item":[192],"(\"much":[193],"improved\"":[194],"\"very":[196],"much":[197,228,232],"improved\");":[198],"mean":[199,260,268,282],"change":[200],"from":[201],"baseline":[202,261,283],"Liebowitz":[205,249],"Social":[206,250],"Anxiety":[207,251],"Scale":[208,252],"total":[209,253],"score.":[210],"RESULTS:":[211],"Fifty":[212],"(55.0%)":[213],"91":[215],"taking":[217,225],"22":[220],"(23.9%)":[221],"92":[223],"improved":[229,233],"very":[231],"end":[236],"treatment":[238,310,320,344],"(odds":[239],"ratio":[240],"[OR],":[241],"3.88;":[242],"95%":[243],"confidence":[244],"interval":[245],"[CI],":[246],"2.81-5.36).":[247],"Mean":[248],"scores":[254],"reduced":[256,341],"by":[257,266,342],"39.1%":[258],"(the":[259,281],"score":[262,284],"78.0":[264],"declined":[265,287],"30.5":[270],"points":[271,289],"follow-up)":[273,291],"group":[277],"compared":[278],"17.4%":[280],"83.5":[286],"14.5":[288],"group,":[295],"difference":[297],"21.7%":[299],"(95%":[300],"CI,":[301],"8.7%-34.7%)":[302],"favoring":[303],"paroxetine.":[304],"CONCLUSIONS:":[305],"Paroxetine":[306],"an":[308],"Short-term":[317],"(ie,":[318],"11-week)":[319],"results":[321],"substantial":[323],"clinically":[325],"meaningful":[326],"reductions":[327],"symptoms":[329],"disability.":[331],"Future":[332],"should":[334],"test":[335],"whether":[336],"these":[337],"may":[338],"further":[340],"extended":[343],"supplementation":[346],"specific":[348],"educational-cognitive-behavioral":[349],"techniques.":[350]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":13}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}